900120.KS · 씨엑스아이

South Korea · RS rating 6 · As of 2026-10-14

Price4,595.00 KRW
1-day change+30.0%
RS rating (overall / 1M / 3M / 12M)6 / 18 / 15 / 7
StageBasing
Composite / Minervini / CANSLIM score27 / 11 / 31
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q+31.9%
Sales growth Q/Q+1.9%
Distance from 52-week high+64.6%
Market cap (USD)$7.8M
Open South Korea in the interactive screener